Comparing the performance of gene expression assays in breast cancer

被引:2
作者
Suthers, Graeme K. [1 ,2 ]
机构
[1] Sonic Healthcare Australia, 14 Giffnock Ave, Macquarie Park, NSW 2113, Australia
[2] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia
关键词
D O I
10.1002/ijc.32290
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1162 / 1162
页数:1
相关论文
共 6 条
[1]   High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial [J].
Nielsen, Torsten O. ;
Jensen, Maj-Brit ;
Burugu, Samantha ;
Gao, Dongxia ;
Jorgensen, Charlotte L. Tykjaer ;
Balslev, Eva ;
Ejlertsen, Bent .
CLINICAL CANCER RESEARCH, 2017, 23 (04) :946-953
[2]   PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer [J].
Ohara, Ako Matsushita ;
Naoi, Yasuto ;
Shimazu, Kenzo ;
Kagara, Naofumi ;
Shimoda, Masafumi ;
Tanei, Tomonori ;
Miyake, Tomohiro ;
Kim, Seung Jin ;
Noguchi, Shinzaburo .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (03) :533-543
[3]   Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer A Secondary Analysis of a Randomized Clinical Trial [J].
Sestak, Lvana ;
Buus, Richard ;
Cuzick, Jack ;
Dubsky, Peter ;
Monenwett, Ralf ;
Denkert, Carsten ;
Ferree, Sean ;
Sgroi, Dennis ;
Schnabel, Catherine ;
Baehner, Frederick L. ;
Mallon, Elizabeth ;
Dowsett, Mitch .
JAMA ONCOLOGY, 2018, 4 (04) :545-553
[4]   Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer [J].
Sparano, J. A. ;
Gray, R. J. ;
Makower, D. F. ;
Pritchard, K. I. ;
Albain, K. S. ;
Hayes, D. F. ;
Geyer, C. E., Jr. ;
Dees, E. C. ;
Goetz, M. P. ;
Olson, J. A., Jr. ;
Lively, T. ;
Badve, S. S. ;
Saphner, T. J. ;
Wagner, L. I. ;
Whelan, T. J. ;
Ellis, M. J. ;
Paik, S. ;
Wood, W. C. ;
Ravdin, P. M. ;
Keane, M. M. ;
Moreno, H. L. Gomez ;
Reddy, P. S. ;
Goggins, T. F. ;
Mayer, I. A. ;
Brufsky, A. M. ;
Toppmeyer, D. L. ;
Kaklamani, V. G. ;
Berenberg, J. L. ;
Abrams, J. ;
Sledge, G. W., Jr. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (02) :111-121
[5]   Prospective Validation of a 21-Gene Expression Assay in Breast Cancer [J].
Sparano, J. A. ;
Gray, R. J. ;
Makower, D. F. ;
Pritchard, K. I. ;
Albain, K. S. ;
Hayes, D. F. ;
Geyer, C. E., Jr. ;
Dees, E. C. ;
Perez, E. A. ;
Olson, J. A., Jr. ;
Zujewski, J. A. ;
Lively, T. ;
Badve, S. S. ;
Saphner, T. J. ;
Wagner, L. I. ;
Whelan, T. J. ;
Ellis, M. J. ;
Paik, S. ;
Wood, W. C. ;
Ravdin, P. ;
Keane, M. M. ;
Gomez Moreno, H. L. ;
Reddy, P. S. ;
Goggins, T. F. ;
Mayer, I. A. ;
Brufsky, A. M. ;
Toppmeyer, D. L. ;
Kaklamani, V. G. ;
Atkins, J. N. ;
Berenberg, J. L. ;
Sledge, G. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (21) :2005-2014
[6]   Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer [J].
Varga, Zsuzsanna ;
Sinn, Peter ;
Seidman, Andrew D. .
INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (04) :882-893